Intelligence · Clinical Pipeline
Novo Nordisk A/S Pipeline
All ClinicalTrials.gov programs at Novo Nordisk A/S — phase, modality, and trial IDs.
- Programs
- 4
Quick answer
Novo Nordisk A/S has 4 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Faster Aspart
Novo Nordisk A/S
Diabetes Mellitus, Type 1
1 trial -
NNC 0172-0000-2021
Novo Nordisk A/S
Congenital Bleeding Disorder
1 trial -
NNC0480-0389
Novo Nordisk A/S
Healthy Volunteers Type 2 Diabetes
1 trial -
To evaluate the pharmacokinetics and safety of nolasiban
Novo Nordisk A/S
not applicable (submitted trial is a pharmacokinetic study in healthy subjects)
1 trial
Frequently asked questions
How many pipeline programs does Novo Nordisk A/S have?
4 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs